These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23737681)

  • 1. Salpingectomy to prevent ovarian cancer: A Countercurrents Series.
    Narod SA
    Curr Oncol; 2013 Jun; 20(3):145-7. PubMed ID: 23737681
    [No Abstract]   [Full Text] [Related]  

  • 2. Current Updates on Salpingectomy for the Prevention of Ovarian Cancer and Its Practice Patterns Worldwide.
    Dhakal S; Zheng YX; Yi XF
    Chin Med Sci J; 2017 Sep; 32(3):185-192. PubMed ID: 28956746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Committee opinion no. 620: Salpingectomy for ovarian cancer prevention.
    Obstet Gynecol; 2015 Jan; 125(1):279-281. PubMed ID: 25560145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention.
    Ghezelayagh TS; Stewart LE; Norquist BM; Bowen DJ; Yu V; Agnew KJ; Pennington KP; Swisher EM
    Fam Cancer; 2020 Apr; 19(2):143-151. PubMed ID: 32096072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
    Cadish LA; Shepherd JP; Barber EL; Ridgeway B
    Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
    Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
    Venkatesh KK; Clark LH; Stamilio DM
    Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salpingectomy to reduce risk of ovarian cancer in women at average risk.
    Arruda J
    Menopause; 2019 Sep; 26(9):1059-1061. PubMed ID: 31453970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salpingectomy and Ovarian Cancer Prevention.
    Harris AL
    Nurs Womens Health; 2015 Dec-2016 Jan; 19(6):543-9. PubMed ID: 26682662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
    Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
    Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
    Kotsopoulos J; Narod SA
    Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between pelvic inflammatory disease and subsequent salpingectomy on the risk for ovarian cancer.
    Falconer H; Yin L; Salehi S; Altman D
    Eur J Cancer; 2021 Mar; 145():38-43. PubMed ID: 33418235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
    Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer risk after salpingectomy for ectopic pregnancy or hydrosalpinx: results of the OCASE nationwide population-based database study.
    van Lieshout LAM; Piek JMJ; Verwijmeren K; Houterman S; Siebers AG; de Hullu JA; Bekkers RLM
    Hum Reprod; 2021 Jan; 36(1):211-218. PubMed ID: 33156914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
    Falconer H; Yin L; Grönberg H; Altman D
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technique for bilateral salpingectomy at the time of Cesarean delivery: a case series.
    Duncan JR; Schenone MH; Mari G
    Contraception; 2017 May; 95(5):509-511. PubMed ID: 28263747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
    Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.
    Harmsen MG; IntHout J; Arts-de Jong M; Hoogerbrugge N; Massuger LFAG; Hermens RPMG; de Hullu JA
    Obstet Gynecol; 2016 Jun; 127(6):1054-1063. PubMed ID: 27159752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.